181 related articles for article (PubMed ID: 7932409)
1. The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis.
Després N; Boire G; Lopez-Longo FJ; Ménard HA
J Rheumatol; 1994 Jun; 21(6):1027-33. PubMed ID: 7932409
[TBL] [Abstract][Full Text] [Related]
2. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis.
Hayem G; Chazerain P; Combe B; Elias A; Haim T; Nicaise P; Benali K; Eliaou JF; Kahn MF; Sany J; Meyer O
J Rheumatol; 1999 Jan; 26(1):7-13. PubMed ID: 9918234
[TBL] [Abstract][Full Text] [Related]
3. Anti-Sa sera from patients with rheumatoid arthritis contain at least 2 different subpopulations of anti-Sa antibodies.
Escalona M; López-Longo FJ; González CM; Monteagudo I; Rodríguez-Mahou M; Grau R; Carreño L
J Rheumatol; 2002 Oct; 29(10):2053-60. PubMed ID: 12375311
[TBL] [Abstract][Full Text] [Related]
4. [Study of the proteins associated with Sa antigen].
Chen H; Yao ZJ; Tang FL
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(27):1896-900. PubMed ID: 17064527
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
6. Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritis.
López-Longo FJ; Rodríguez-Mahou M; Sánchez-Ramón S; Estecha A; Balsera M; Plaza R; Fernández-Cruz E; Pérez LC
J Rheumatol; 2006 Aug; 33(8):1476-81. PubMed ID: 16881106
[TBL] [Abstract][Full Text] [Related]
7. Anti-Sa antibody in Chinese rheumatoid arthritis.
Xu S; Tang F; Shi L; Gan X; Shi Y; Cheng L; Li J; Dong Y
Chin Med J (Engl); 1998 Mar; 111(3):204-7. PubMed ID: 10374415
[TBL] [Abstract][Full Text] [Related]
8. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.
Boire G; Cossette P; de Brum-Fernandes AJ; Liang P; Niyonsenga T; Zhou ZJ; Carrier N; Daniel C; Ménard HA
Arthritis Res Ther; 2005; 7(3):R592-603. PubMed ID: 15899046
[TBL] [Abstract][Full Text] [Related]
9. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
10. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
11. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
[TBL] [Abstract][Full Text] [Related]
12. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis.
Hill JA; Al-Bishri J; Gladman DD; Cairns E; Bell DA
J Rheumatol; 2006 Nov; 33(11):2115-9. PubMed ID: 16924693
[TBL] [Abstract][Full Text] [Related]
13. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
14. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis.
Saulot V; Vittecoq O; Charlionet R; Fardellone P; Lange C; Marvin L; Machour N; Le Loët X; Gilbert D; Tron F
Arthritis Rheum; 2002 May; 46(5):1196-201. PubMed ID: 12115223
[TBL] [Abstract][Full Text] [Related]
15. [Novel autoantibodies for the diagnosis of rheumatoid arthritis].
Steiner G; Smolen JS
Z Rheumatol; 2002 Dec; 61(6):667-73. PubMed ID: 12491130
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
[TBL] [Abstract][Full Text] [Related]
17. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
[TBL] [Abstract][Full Text] [Related]
18. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]